NCT00624754View on ClinicalTrials.gov

Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Obstructive Airway Disease
Interventions
DRUG

Formoterol/Budesonide

Budesonide/Formoterol 400/12: 800 µg b.i.d for 1 month

DRUG

lactose

Lactose 2 puffs b.i.d for 1 month

Trial Locations (1)

75010

Hôpital Saint Louis, Paris

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER